CD274 and neoplasm: Besides transforming the immunosuppressive tumor microenvironment into a pro-inflammatory one, the restoration of these PD-L1-inhibiting miRs can regulate various oncogenic signaling pathways, inhibit the de novo expression of oncoproteins, like PD-L1, in TNBC cells.